Advancing the science and practice of ophthalmology with the latest clinical and scientific based research and studies
London
Joined May 2015
- Tweets2.3K
- Following169
- Followers5.2K
- Likes398
Eye Journal retweeted
In collaboration with Springer Nature’s leading ophthalmology journal, Eye, our upcoming CME-accredited webinar will cover the latest developments in the diagnosis, grading, and management of #DryEyeDisease.
Register now 👉️ buff.ly/WC3aiko
#EyeMed
@Eye_Journal
Eye Journal retweeted
#DryEyeDisease is widespread and can affect comfort, vision, and daily life, yet its causes and symptoms vary.
In this webinar, discover how new research and clinical tools are changing how the condition is assessed and managed.
👉buff.ly/ghkOzp9
#EyeMed
@Eye_Journal
Eye Journal retweeted
#DryEye disease can seriously impact quality of life, yet it’s often hard to diagnose and manage.
Join our expert led webinar to learn how new science, better diagnostics, and emerging treatments are improving long term care.
👉 buff.ly/ghkOzp9
#EyeMed
@Eye_Journal
Eye Journal retweeted
We’re delighted to announce a new special section in
@Eye_Journal on Thyroid Eye Disease and Orbital Inflammation.
This is a timely moment: clinical trials, translational science and targeted therapies are reshaping how we think about inflammatory orbital disease, patient selection, outcomes and service design.
#TED #OrbitalInflammation #Ophthalmology #ClinicalTrials
nature.com/eye
[email protected]
Call for submissions: Eye Special Section on Thyroid Eye Disease and Orbital Inflammation
Share research on clinical care, therapies, imaging, and outcomes
Expressions of Interest: 30 June 2026
Deadline: 30 Dec 2026
Editors: Vickie Lee, @DrNimaGhadiri
nature.com/eye/
Eye Journal retweeted
DED is highly prevalent yet challenging to diagnose and treat.
Join us and discover the latest developments in pathogenesis, diagnostics, and therapies, and gain practical guidance on DED management.
Register now 👉 buff.ly/ghkOzp9
#EyeMed #DryEye
@Eye_Journal
Eye Journal retweeted
Naomi Tan and I are delighted to invite you to the Paediatric Ophthalmology Symposium at the @RCOphth Annual Congress 2026 in Manchester.
Early bird registration is open until 24th March 2026: rcophth.ac.uk/events-courses…
Please share! See you there 👀
Eye Journal retweeted
Pleased to share our paper published in @Eye_Journal:
Feasibility and reproducibility of handheld and table-mounted optical coherence tomography in children with craniosynostosis
nature.com/articles/s41433-0…
Eye Journal retweeted
New UK clinical guidance published in @Eye_Journal aims to improve the identification and management of Charles Bonnet syndrome, a common but under-recognised consequence of sight loss.
Read the full article: moorfieldsbrc.nihr.ac.uk/new…
@esmesumbrella | @Moorfields | @EyeCharity
Eye Journal retweeted
📊 Investigating inherited retinal disorders in Scotland over 5 years!
🧬 RP & Stargardt are the most common diagnoses; 67% receive a molecular diagnosis, with ABCA4 & USH2A most common.
🔍 Benchmark for testing & future care.
nature.com/articles/s41433-0…
In @Eye_Journal
Eye Journal retweeted
Ocugen announced today the publication of Phase 1 GARDian1 trial data for #OCU410ST in @Eye_Journal. Results show favorable safety and tolerability with meaningful benefits in #Stargardtdisease after 12 months.
Read more: bit.ly/4pzs0cE
Eye Journal retweeted
Are medical instructions designed for the patient's convenience, or the doctor's?
With 1 in 6 UK adults facing literacy gaps, we overhauled our surgical post-op guides: fewer words, more visuals & video.
Better access = better outcomes.
nature.com/articles/s41433-0…
#Ophthalmology
Eye Journal retweeted
👶🔍 “Red reflex” isn’t always red — and it’s causing avoidable referrals
We report:
Low rates of true pathology
Higher rates of false positive referrals in non-caucasian infants
nature.com/articles/s41433-0…
In: @Eye_Journal
Eye Journal retweeted
Our paper is now out in Eye (@Eye_Journal) by @RCOphth!
Adding tacrolimus to steroids could help reduce the risk of graft failure in high-risk PKP cases compared with steroids alone.
Check it out: nature.com/articles/s41433-0…
Eye Journal retweeted
💡An analysis of #optometrist-performed #SLT in the U.K. showed success rates upward of 65% and a 2.2% rate of adverse events.
More on the study published in @eye_journal. 👇
healio.com/news/optometry/20…
Eye Journal retweeted
Exciting news!
Our thanks to College member Patrick Yu-Wai-Man for his work on the NICE appraisal.
Hundreds of adults and teenagers with Leber’s hereditary optic neuropathy (a rare, inherited eye disease) are set to benefit after NICE recommended the first treatment for use on the NHS in England today.
Find out more about idebenone: nice.org.uk/guidance/indevel…
ALT Healthcare professional conducts eye examination. Overlaid text reads: It is estimated around 250 people in England could be set to benefit after final draft guidance recommended idebenone for Leber’s hereditary optic neuropathy.
ALT Professional headshot of Helen Knight, Director of Medicines Evaluation at NICE. Overlaid quote reads: "The evidence shows this treatment could improve people's eyesight and help their quality of life by allowing them to live independently for longer."
Eye Journal retweeted
We’re pleased to share our latest publication in @Eye_Journal (Nature):
🔬Brolucizumab clinical & safety outcomes in a neovascular Age-related Macular Degeneration database: Fight Retinal Blindness Spain (FRB Spain 🇪🇸)👁️
A national study by @hospitalclinic @idibaps @UniBarcelona
Eye Journal retweeted
We're very proud of this impressive achievement for our journal!
Well done to everyone involved 👏
Very pleased to share that Eye's 2024 #impactfactor has risen to 3.2. Now ranked 17th out of 98 journals in #Ophthalmology
Thank you to our authors, reviewers, and editorial board members for your invaluable contributions!
